Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (41 ops.)
Latest filing published 29 May 2025 for GYRE THERAPEUTICS, INC., €18k. Read the official filing
Filing timeline
BuySaleSongjiang Ma
Insider track record
Disclosed buys
0
Disclosed sells
41
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Songjiang Ma: trading record in brief
This profile gathers the share dealings of Songjiang Ma in Gyre Therapeutics, Inc. Over a trading history stretching from 17 December 2024 to 28 May 2025, the count stands at 41 filings.
On the market, this insider has only sold: 41 sales, €732k in total. In 2025 alone, the filings show no purchases and 37 sales.
On 29 May 2025 came the latest disclosure, an open-market sale for €18k in Gyre Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Songjiang Ma
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations39 total
2,000 shares@ US$10.28Common StockSEC:0001140361-25-020754:0
558 shares@ US$10.07Common StockSEC:0001140361-25-020754:1
2,000 shares@ US$11.252.9% of flowCommon StockSEC:0001140361-25-020156:0
2,000 shares@ US$11.312.9% of flowCommon StockSEC:0001140361-25-019893:0
20 shares@ US$11.300.0% of flowCommon StockSEC:0001140361-25-019468:0
2,000 shares@ US$10.562.8% of flowCommon StockSEC:0001140361-25-018927:0
174 shares@ US$10.000.2% of flowCommon StockSEC:0001140361-25-010234:0
2,000 shares@ US$10.132.7% of flowCommon StockSEC:0001140361-25-009877:0
2,000 shares@ US$12.093.2% of flowCommon StockSEC:0001140361-25-009424:0
2,000 shares@ US$11.803.2% of flowCommon StockSEC:0001140361-25-009017:0
2,000 shares@ US$11.403.1% of flowCommon StockSEC:0001140361-25-008623:0
53 shares@ US$13.030.1% of flowCommon StockSEC:0001140361-25-008091:0
2,000 shares@ US$10.983.0% of flowCommon StockSEC:0001140361-25-007602:0
2,000 shares@ US$11.233.1% of flowCommon StockSEC:0001140361-25-007173:0
2,000 shares@ US$11.333.1% of flowCommon StockSEC:0001140361-25-006738:0
2,000 shares@ US$11.373.2% of flowCommon StockSEC:0001140361-25-006273:0
1,818 shares@ US$11.843.0% of flowCommon StockSEC:0001140361-25-005842:0
2,000 shares@ US$12.293.4% of flowCommon StockSEC:0001140361-25-005420:0
2,000 shares@ US$11.943.3% of flowCommon StockSEC:0001140361-25-005113:0
2,000 shares@ US$11.493.2% of flowCommon StockSEC:0001140361-25-004744:0
2,000 shares@ US$11.903.4% of flowCommon StockSEC:0001140361-25-004126:0
2,000 shares@ US$12.853.6% of flowCommon StockSEC:0001140361-25-003831:0
2,000 shares@ US$11.623.3% of flowCommon StockSEC:0001140361-25-003426:0
2,000 shares@ US$11.513.2% of flowCommon StockSEC:0001140361-25-002995:0
2,000 shares@ US$11.433.2% of flowCommon StockSEC:0001140361-25-002702:0
25 of 39 declarations
